An observational study in Pulmonary and Renal State, sponsored by Minia University. Status unknown. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-04-01.
Sponsored by Minia University · Observational
Tracking post- corona virus infection pulmonary and renal complications
Mortality from pulmonary and renal system is highly noticable with COVID-19 pandemic . We trying to monitor compliction
1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.
Browse Respiratory Distress Syndrome studies →Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
All COVID positive population
Exclusion Criteria:
follow up population
renal function
serum creatinine
Time frame: 12 weeks
No study locations are listed for this record.
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome→
Minia University